Barely Significant
← all excerpts

Efficacy of tiotropium-olodaterol fixed-dose combination in COPD.

Int J Chron Obstruct Pulmon Dis · 2016 · PMC5167492 · PMID 28008243

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

did not reach statistical significanceno p-value reported
These differences did not reach statistical significance. 27 , 42 Comparison between TIO/OLO 5/5 μg and OLO 5 μg monotherapy As in the comparison between once-daily TIO/OLO 5/5 μg FDC and once-daily TIO 5 μg, differences between TIO/OLO 5/5 μg FDC once-daily and OLO 5 μg once-daily, both administered via the Respimat soft-mist inhaler, were generally statistically but not clinically significant in favor of dual bronchodilatation ( Tables 2 and 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.